A Randomized Comparison of two Short Intensive Chemotherapy Regimens in Children and Young Adults With Osteosarcoma: Results in Patients With Metastases: A Study of the European Osteosarcoma Intergroup | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Prognostic factors and outcomes for osteosarcoma: an international collaboration

January 2009

We aimed to evaluate the prognostic significance of traditional clinical predictors in osteosarcoma ...

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

Gaspar, Nathalie
Occean, Bob-Valéry
Pacquement, Hélène
Bompas, Emmanuelle
Bouvier, Corine
Brisse, Hervé,
Castex, Marie-Pierre
Cheurfa, Nadir
Corradini, Nadège
Delaye, Jessy
Entz-Werlé, Natacha
Gentet, Jean-Claude
Italiano, Antoine
Lervat, Cyril
Marec-Berard, Perrine
Mascard, Eric
Rédini, Françoise
Saumet, Laure
Schmitt, Claudine
Tabone, Marie-Dominique
Verite-Goulard, Cécile
Le Deley, Marie-Cécile
Piperno-Neumann, Sophie
Brugieres, Laurence

November 2017

International audienceBACKGROUND:In most countries, reference chemotherapy for osteosarcoma is MAP r...

EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

January 2018

INTRODUCTION: The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective inte...

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

January 2018

The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective international stud...

Extraskeletal osteosarcoma:A European Musculoskeletal Oncology Society study on 266 patients

Longhi, A.
Bielack, S.
Grimer, R.
Whelan, J.
Windhager, R
Leithner, Andreas
Gronchi, A.
Biau, David J.
Jutte, P.
Krieg, A. H.
Klenke, Frank M.
Grignani, G.
Donati, D. M.
Capanna, R.
Casanova, Jose
Gerrand, Craig
Bisogno, G.
Hecker-Nolting, Stefanie
De Lisa, M.
D'Ambrosio, Lia
Willegger, M.
Scoccianti, G.
FERRARI, S

March 2017

Purpose: Prognosis of extraskeletal osteosarcoma (ESOS) is reported to be poorer than that of skelet...

Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients

Longhi, A.
Bielack, S.
Grimer, R.
Whelan, J.
Windhager, R
Leithner, Andreas
Gronchi, A.
Biau, David J.
Jutte, P.
Krieg, A. H.
Klenke, Frank M.
Grignani, G.
Donati, D. M.
Capanna, R.
Casanova, Jose
Gerrand, Craig
Bisogno, G.
Hecker-Nolting, Stefanie
De Lisa, M.
D'Ambrosio, Lia
Willegger, M.
Scoccianti, G.
FERRARI, S

March 2017

Purpose: Prognosis of extraskeletal osteosarcoma (ESOS) is reported to be poorer than that of skelet...

A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma

Voute, Pauline
Souhami, RL
Nooij, M.
Somers, R.
Cortes-Funes, H
van der Eijken, JW
Pringle, J
Hogendoorn, PCW
Kirkpatrick, A
Uscinska, Barbara M.
Van Glabbeke, Martine
Machin, D
Weeden, S

January 1999

Background: Despite advances in the treatment of primary limb osteosarcoma, the outcome of patients ...

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

February 2015

BackgroundFour international study groups undertook a large study in resectable osteosarcoma, which ...

Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

Piperno-Neumann, Sophie
Ray-Coquard, Isabelle
Occean, Bob-Valéry
Laurence, Valérie
Cupissol, Didier
Perrin, Christophe
Penel, Nicolas
Bompas, Emmanuelle
Rios, Maria
Le Cesne, Axel
Italiano, Antoine
Anract, Philippe
de Pinieux, Gonzague
Collard, Olivier
Bertucci, François
Duffaud, Florence
Le Deley, Marie-Cécile
Delaye, Jessy
Brugières, Laurence
Blay, Jean-Yves
Piperno‐neumann, Sophie
Ray‐coquard, Isabelle
Occean, Bob‐valéry
Pinieux, Gonzague,
Le Deley, Marie‐cécile
Blay, Jean‐yves

March 2019

International audienceIn the OS2006 study, patients younger than 18 years were treated with a methot...

European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma

Roelof van Ewijk
Nikolas Herold
Fredrik Baecklund
Daniel Baumhoer
Kjetil Boye
Nathalie Gaspar
Semi B. Harrabi
Lianne M. Haveman
Stefanie Hecker-Nolting
Laura Hiemcke-Jiwa
Valentine Martin
Cristina Mata Fernández
Emanuela Palmerini
Michiel A.J. van de Sande
Sandra J. Strauss
Stefan S. Bielack
Leo Kager

December 2023

Osteosarcoma is a challenging disease requiring multidisciplinary management in expert centers for o...

Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma

Hansen, Aaron R.
Hughes, Brett G.
Paul, Sanjoy
Steadman, Peter
Sommerville, Scott
Dickinson, Ian C.
Walpole, Euan T.
Thomson, Damien B.
Mar Fan, Helen G.
Joubert, Warren L.

June 2016

Aims: Perioperative chemotherapy has improved the prognosis for patients with operable osteosarcoma....

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup

Lewis, Ian J
Nooij, Marianne A
Whelan, Jeremy
Sydes, Matthew R
Grimer, Robert
Hogendoorn, Pancras C. W
Memon, Muhammad A
Weeden, Simon
Uscinska, Barbara M
van Glabbeke, Martine
Kirkpatrick, Anne
Hauben, Esther
Craft, Alan W
Taminiau, Antonie H. M

January 2007

Background Previous randomized controlled trials that used the two-drug chemotherapy regimen of cisp...

Survival and prognosis with osteosarcoma : outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

January 2019

Background: High-grade osteosarcoma is a primary malignant bone tumour mainly affecting children and...

Prognostic factors and outcomes for osteosarcoma: an international collaboration

January 2009

We aimed to evaluate the prognostic significance of traditional clinical predictors in osteosarcoma ...

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

Gaspar, Nathalie
Occean, Bob-Valéry
Pacquement, Hélène
Bompas, Emmanuelle
Bouvier, Corine
Brisse, Hervé,
Castex, Marie-Pierre
Cheurfa, Nadir
Corradini, Nadège
Delaye, Jessy
Entz-Werlé, Natacha
Gentet, Jean-Claude
Italiano, Antoine
Lervat, Cyril
Marec-Berard, Perrine
Mascard, Eric
Rédini, Françoise
Saumet, Laure
Schmitt, Claudine
Tabone, Marie-Dominique
Verite-Goulard, Cécile
Le Deley, Marie-Cécile
Piperno-Neumann, Sophie
Brugieres, Laurence

November 2017

International audienceBACKGROUND:In most countries, reference chemotherapy for osteosarcoma is MAP r...

EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

January 2018

INTRODUCTION: The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective inte...

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

January 2018

The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective international stud...

Extraskeletal osteosarcoma:A European Musculoskeletal Oncology Society study on 266 patients

Longhi, A.
Bielack, S.
Grimer, R.
Whelan, J.
Windhager, R
Leithner, Andreas
Gronchi, A.
Biau, David J.
Jutte, P.
Krieg, A. H.
Klenke, Frank M.
Grignani, G.
Donati, D. M.
Capanna, R.
Casanova, Jose
Gerrand, Craig
Bisogno, G.
Hecker-Nolting, Stefanie
De Lisa, M.
D'Ambrosio, Lia
Willegger, M.
Scoccianti, G.
FERRARI, S

March 2017

Purpose: Prognosis of extraskeletal osteosarcoma (ESOS) is reported to be poorer than that of skelet...

Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients

Longhi, A.
Bielack, S.
Grimer, R.
Whelan, J.
Windhager, R
Leithner, Andreas
Gronchi, A.
Biau, David J.
Jutte, P.
Krieg, A. H.
Klenke, Frank M.
Grignani, G.
Donati, D. M.
Capanna, R.
Casanova, Jose
Gerrand, Craig
Bisogno, G.
Hecker-Nolting, Stefanie
De Lisa, M.
D'Ambrosio, Lia
Willegger, M.
Scoccianti, G.
FERRARI, S

March 2017

Purpose: Prognosis of extraskeletal osteosarcoma (ESOS) is reported to be poorer than that of skelet...

A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma

Voute, Pauline
Souhami, RL
Nooij, M.
Somers, R.
Cortes-Funes, H
van der Eijken, JW
Pringle, J
Hogendoorn, PCW
Kirkpatrick, A
Uscinska, Barbara M.
Van Glabbeke, Martine
Machin, D
Weeden, S

January 1999

Background: Despite advances in the treatment of primary limb osteosarcoma, the outcome of patients ...

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

February 2015

BackgroundFour international study groups undertook a large study in resectable osteosarcoma, which ...

Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

Piperno-Neumann, Sophie
Ray-Coquard, Isabelle
Occean, Bob-Valéry
Laurence, Valérie
Cupissol, Didier
Perrin, Christophe
Penel, Nicolas
Bompas, Emmanuelle
Rios, Maria
Le Cesne, Axel
Italiano, Antoine
Anract, Philippe
de Pinieux, Gonzague
Collard, Olivier
Bertucci, François
Duffaud, Florence
Le Deley, Marie-Cécile
Delaye, Jessy
Brugières, Laurence
Blay, Jean-Yves
Piperno‐neumann, Sophie
Ray‐coquard, Isabelle
Occean, Bob‐valéry
Pinieux, Gonzague,
Le Deley, Marie‐cécile
Blay, Jean‐yves

March 2019

International audienceIn the OS2006 study, patients younger than 18 years were treated with a methot...

European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma

Roelof van Ewijk
Nikolas Herold
Fredrik Baecklund
Daniel Baumhoer
Kjetil Boye
Nathalie Gaspar
Semi B. Harrabi
Lianne M. Haveman
Stefanie Hecker-Nolting
Laura Hiemcke-Jiwa
Valentine Martin
Cristina Mata Fernández
Emanuela Palmerini
Michiel A.J. van de Sande
Sandra J. Strauss
Stefan S. Bielack
Leo Kager

December 2023

Osteosarcoma is a challenging disease requiring multidisciplinary management in expert centers for o...

Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma

Hansen, Aaron R.
Hughes, Brett G.
Paul, Sanjoy
Steadman, Peter
Sommerville, Scott
Dickinson, Ian C.
Walpole, Euan T.
Thomson, Damien B.
Mar Fan, Helen G.
Joubert, Warren L.

June 2016

Aims: Perioperative chemotherapy has improved the prognosis for patients with operable osteosarcoma....

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup

Lewis, Ian J
Nooij, Marianne A
Whelan, Jeremy
Sydes, Matthew R
Grimer, Robert
Hogendoorn, Pancras C. W
Memon, Muhammad A
Weeden, Simon
Uscinska, Barbara M
van Glabbeke, Martine
Kirkpatrick, Anne
Hauben, Esther
Craft, Alan W
Taminiau, Antonie H. M

January 2007

Background Previous randomized controlled trials that used the two-drug chemotherapy regimen of cisp...

Survival and prognosis with osteosarcoma : outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

January 2019

Background: High-grade osteosarcoma is a primary malignant bone tumour mainly affecting children and...

Prognostic factors and outcomes for osteosarcoma: an international collaboration

January 2009

We aimed to evaluate the prognostic significance of traditional clinical predictors in osteosarcoma ...